Discover the Impact of GEMTESA®: A Selective β3-adrenergic Agonist for Effective OAB Treatment
Posted about 2 years ago by Lula Johnson
Reminder: Today, March 29, 2022, please join Elizabeth Williams MD for a presentation on" A Selective β3-adreneric Agonist for Effective OAB Treatment". Presentation to begin at 6:00 PM followed by a brief business meeting. Register on the MCNAP Link AND RSVP to Lindsay Underwood at:
636-233-9318